RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

IPCA Laboratories Equity 2024

IPCA Laboratories Equity

58.42 B INR

IPCA Laboratories Dividend yield

0.15 %

Ticker

IPCALAB.NS

ISIN

INE571A01038

In 2024, IPCA Laboratories's equity was 58.42 B INR, a 6.37% increase from the 54.92 B INR equity in the previous year.

IPCA Laboratories Aktienanalyse

What does IPCA Laboratories do?

IPCA Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing IPCA Laboratories's Equity

IPCA Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IPCA Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IPCA Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IPCA Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IPCA Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IPCA Laboratories Stock

What is the equity of IPCA Laboratories this year?

IPCA Laboratories has equity of 58.42 B INR this year.

What was the equity of IPCA Laboratories compared to the previous year?

The equity of IPCA Laboratories has increased/decreased by 6.37% increased compared to the previous year.

What impact does a high equity have on investors of IPCA Laboratories?

A high equity is advantageous for investors of IPCA Laboratories as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of IPCA Laboratories?

A low equity can be a risk for investors of IPCA Laboratories, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of IPCA Laboratories affect the company?

An increase in equity of IPCA Laboratories can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of IPCA Laboratories affect the company?

A reduction in equity of IPCA Laboratories can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of IPCA Laboratories?

Some factors that can affect the equity of IPCA Laboratories include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of IPCA Laboratories so important for investors?

The equity of IPCA Laboratories is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can IPCA Laboratories take to change the equity?

To change equity, IPCA Laboratories can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does IPCA Laboratories pay?

Over the past 12 months, IPCA Laboratories paid a dividend of 2 INR . This corresponds to a dividend yield of about 0.15 %. For the coming 12 months, IPCA Laboratories is expected to pay a dividend of 2.28 INR.

What is the dividend yield of IPCA Laboratories?

The current dividend yield of IPCA Laboratories is 0.15 %.

When does IPCA Laboratories pay dividends?

IPCA Laboratories pays a quarterly dividend. This is distributed in the months of December, December, December, December.

How secure is the dividend of IPCA Laboratories?

IPCA Laboratories paid dividends every year for the past 10 years.

What is the dividend of IPCA Laboratories?

For the upcoming 12 months, dividends amounting to 2.28 INR are expected. This corresponds to a dividend yield of 0.18 %.

In which sector is IPCA Laboratories located?

IPCA Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IPCA Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IPCA Laboratories from 12/5/2023 amounting to 2 INR, you needed to have the stock in your portfolio before the ex-date on 11/22/2023.

When did IPCA Laboratories pay the last dividend?

The last dividend was paid out on 12/5/2023.

What was the dividend of IPCA Laboratories in the year 2023?

In the year 2023, IPCA Laboratories distributed 4 INR as dividends.

In which currency does IPCA Laboratories pay out the dividend?

The dividends of IPCA Laboratories are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IPCA Laboratories

Our stock analysis for IPCA Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IPCA Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.